A House Energy and Commerce subcommittee convened the hearing to assess the current forecast for this flu season, federal efforts to mitigate illnesses, and ongoing research into new flu vaccines and treatments.
Topics of discussion included common reasons the general public does not opt to get a flu vaccine; the importance of supporting local health departments to track flu data; and the U.S.’s domestic manufacturing capacity for flu vaccines, medications and other supplies in case of a flu pandemic.
The following health officials testified at the hearing:
- Nancy Messonnier, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases
- Anthony Fauci, MD, director of NIH’s National Institute for Allergy and Infectious Diseases
- Robert Kadlec, MD, assistant secretary for preparedness and response for HHS
- Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research
More articles on clinical leadership & infection control:
Everything you need to know about Seattle Children’s mold issues
10 states report widespread flu activity
Care interrupted for 200+ patients at Hawaii hospital after physician accused of sexual assault
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
